Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference
Kiniksa Pharmaceuticals (Nasdaq: KNSA) has announced its upcoming participation in the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Monday, January 13, 2025, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).
Investors and interested parties can access a live webcast of the presentation through the Investors section of Kiniksa's website at www.kiniksa.com. Additionally, a replay of the presentation will be made available on the company's website within approximately 48 hours following the event.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) ha annunciato la sua prossima partecipazione al 43° Annual J.P. Morgan Healthcare Conference. La presentazione è programmata per lunedì 13 gennaio 2025, alle 13:30 ora del Pacifico (16:30 ora dell'Est).
Investitori e parti interessate possono accedere a un webcast live della presentazione attraverso la sezione Investitori del sito web di Kiniksa all'indirizzo www.kiniksa.com. Inoltre, una registrazione dell'evento sarà disponibile sul sito dell'azienda entro circa 48 ore dopo l'evento.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) ha anunciado su próxima participación en la 43ª Conferencia Anual de Atención Médica J.P. Morgan. La presentación está programada para el lunes 13 de enero de 2025, a la 1:30 p.m. hora del Pacífico (4:30 p.m. hora del Este).
Los inversores y partes interesadas pueden acceder a un webcast en vivo de la presentación a través de la sección de Inversores en el sitio web de Kiniksa en www.kiniksa.com. Además, se pondrá disponible una grabación de la presentación en el sitio web de la compañía en aproximadamente 48 horas después del evento.
Kiniksa Pharmaceuticals (Nasdaq: KNSA)는 제43회 연례 J.P. Morgan 헬스케어 컨퍼런스에 참가할 것이라고 발표했습니다. 발표는 2025년 1월 13일 월요일 오후 1시 30분(태평양 표준시), 오후 4시 30분(동부 표준시)에 예정되어 있습니다.
투자자와 관심 있는 분들은 Kiniksa 웹사이트의 투자자 섹션을 통해 발표의 실시간 웹캐스트를 접속할 수 있습니다. 또한, 발표 후 약 48시간 이내에 회사 웹사이트에서 재생이 가능할 것입니다.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) a annoncé sa prochaine participation à la 43e Conférence Annuelle de la Santé J.P. Morgan. La présentation est prévue pour le lundi 13 janvier 2025, à 13h30 heure du Pacifique (16h30 heure de l'Est).
Les investisseurs et les parties intéressées peuvent accéder à un webcast en direct de la présentation via la section Investisseurs du site de Kiniksa à l'adresse www.kiniksa.com. De plus, une rediffusion de la présentation sera disponible sur le site de l'entreprise environ 48 heures après l'événement.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) hat seine bevorstehende Teilnahme an der 43. jährlichen J.P. Morgan Healthcare Conference angekündigt. Die Präsentation ist für Montag, den 13. Januar 2025, um 13:30 Uhr Pazifischer Zeit (16:30 Uhr Ostküstenzeit) geplant.
Investoren und interessierte Parteien können über den Investorenbereich der Kiniksa-Website unter www.kiniksa.com auf ein Live-Webcast der Präsentation zugreifen. Darüber hinaus wird eine Wiederholung der Präsentation innerhalb von etwa 48 Stunden nach der Veranstaltung auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
LONDON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that it will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).
A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
About Kiniksa
Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s immune-modulating assets are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visit www.kiniksa.com.
Every Second Counts! ®
Kiniksa Investor Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com
Kiniksa Media Contact
Tyler Gagnon
(781) 431-9100
tgagnon@kiniksa.com
FAQ
When is Kiniksa Pharmaceuticals (KNSA) presenting at the J.P. Morgan Healthcare Conference 2025?
How can investors watch KNSA's presentation at the J.P. Morgan Healthcare Conference?
When will the replay of KNSA's J.P. Morgan Healthcare Conference presentation be available?
Which annual J.P. Morgan Healthcare Conference is KNSA presenting at in 2025?
